MerTK Receptor Tyrosine Kinase Inhibition As a Potential Strategy to Augment Immune-Mediated Clearance of Acute Myeloid Leukemia

被引：1

作者：

Page, Lauren Shelby ^{[1
]}

Wang, Xiaodong ^{[2
,3
,4
]}

Earp, H. Shelton, III ^{[5
]}

Frye, Stephen ^{[2
,3
,4
]}

Jordan, Craig T. ^{[6
]}

Lee-Sherick, Alisa B. ^{[7
,8
]}

机构：

[1] Univ Colorado, Anschutz Med Campus, Aurora, CO USA

[2] Univ N Carolina, Eshelman Sch Pharm, Chapel Hill, NC USA

[3] Ctr Integrat Chem Biol & Drug Discovery, Chapel Hill, NC USA

[4] Div Chem Biol & Med Chem, Chapel Hill, NC USA

[5] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC USA

[6] Univ Colorado Denver, Div Hematol, Aurora, CO USA

[7] Univ Colorado, Pediat, Aurora, CO USA

[8] Childrens Hosp Colorado, Aurora, CO USA

来源：

BLOOD | 2016年 / 128卷 / 22期

关键词：

D O I：

10.1182/blood.V128.22.4044.4044

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

4044

引用

页数：4

共 50 条

[1] Tyrosine kinase inhibition in acute myeloid leukemia
Altman, Jessica K.
Szilard, Amy K.
Platanias, Leonidas C.
LEUKEMIA & LYMPHOMA, 2013, 54 (07) : 1351 - 1352
[2] MerTK receptor tyrosine kinase is a therapeutic target in pediatric acute leukemia
Graham, Douglas K.
DeRyckere, Deborah
Lee-Sherick, Alisa
Hill, Amanda A.
Minson, Katherine
Xiaodong, Wnag
Zhang, Weihe
Liu, Jing
Frye, Stephen
Earp, H. Shelton
CANCER RESEARCH, 2014, 74 (20)
[3] MER RECEPTOR TYROSINE KINASE AS A POTENTIAL NOVEL TARGET IN ACUTE MYELOID LEUKEMIA
Eisenman, Kristen
Sather, Susan
McGranahan, Amy
Liang, Xiayaun
Desch, Ashley
Cannon, Cara
Martinson, Hollie
Keating, Amy
Graham, Doug
PEDIATRIC BLOOD & CANCER, 2010, 54 (06) : 790 - 790
[4] Mer Receptor Tyrosine Kinase Is A Potential Therapeutic Target in Acute Myeloid Leukemia
Lee-Sherick, Alisa B.
Menachof, Kelly
Eisenman, Kristen M.
McGranahan, Amy
McGary, Colleen
Hunsucker, Sally A.
Schlegel, Jennifer
Armistead, Paul M.
Liang, Xiayuan
Kireev, Dmitri
Janzen, William
Liu, Jing
Stashko, Michael
Norris-Drouin, Jacqueline
Earp, H. Shelton, III
Wang, Xiaodong
Frye, Stephen
DeRyckere, Deborah
Graham, Douglas K.
BLOOD, 2012, 120 (21)
[5] Targeting receptor tyrosine kinase signaling in acute myeloid leukemia
Doepfner, Kathrin T.
Boller, Danielle
Arcaro, Alexandre
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2007, 63 (03) : 215 - 230
[6] Bruton's tyrosine kinase inhibition-An emerging therapeutic strategy in immune-mediated dermatological conditions
Mendes-Bastos, Pedro
Brasileiro, Ana
Kolkhir, Pavel
Frischbutter, Stefan
Scheffel, Joerg
Monino-Romero, Sherezade
Maurer, Marcus
ALLERGY, 2022, 77 (08) : 2355 - 2366
[7] Bone Marrow Stromal Cell Mediated Resistance to Mertk Inhibition in Acute Myeloid Leukemia
Minson, Katherine A.
Huey, Madeline G.
Qiu, Annie
Wang, Xiaodong
Frye, Stephen V.
Earp, H. Shelton
DeRyckere, Deborah
Graham, Douglas K.
BLOOD, 2017, 130
[8] Targeting Myeloid Epithelial Tyrosine Kinase (MERTK) Receptor in Acute Myeloid Leukemia Using a Novel Antibody Drug Conjugate, Rgx-019-MMAE
Tyagi, Anudishi
Siddiqui, Maryam
Kurth, Isabel
Takeda, Shugaku
Eckstrom, Amanda
Borgman, Jenny
Maiti, Abhishek
Battula, Venkata Lokesh
BLOOD, 2023, 142
[9] Autocrine activation of the MET receptor tyrosine kinase in acute myeloid leukemia
Kentsis, Alex
Reed, Casie
Rice, Kim L.
Sanda, Takaomi
Rodig, Scott J.
Tholouli, Eleni
Christie, Amanda
Valk, Peter J. M.
Delwel, Ruud
Vu Ngo
Kutok, Jeffery L.
Dahlberg, Suzanne E.
Moreau, Lisa A.
Byers, Richard J.
Christensen, James G.
Woude, George Vande
Licht, Jonathan D.
Kung, Andrew L.
Staudt, Louis M.
Look, A. Thomas
NATURE MEDICINE, 2012, 18 (07) : 1118 - +
[10] Autocrine activation of the MET receptor tyrosine kinase in acute myeloid leukemia
Alex Kentsis
Casie Reed
Kim L Rice
Takaomi Sanda
Scott J Rodig
Eleni Tholouli
Amanda Christie
Peter J M Valk
Ruud Delwel
Vu Ngo
Jeffery L Kutok
Suzanne E Dahlberg
Lisa A Moreau
Richard J Byers
James G Christensen
George Vande Woude
Jonathan D Licht
Andrew L Kung
Louis M Staudt
A Thomas Look
Nature Medicine, 2012, 18 : 1118 - 1122

← 1 2 3 4 5 →